Nhia, Roche reveals the pharmacological scheme for UDUth Cancer …

The National Health Insurance Authority (NHIA), in collaboration with Roche, a pharmaceutical company, has introduced subsidized cancer drugs to the Usmanu Danfodio University Teaching Hospital, Sokoto (Uduth).

ATIKU device coalition [ADC]: Old Sinners in New Cassock, by Kassim Afegbua

Bashir Isa-Bandawaki, Coordinator of the NHIA, revealed it during the official onboarding of the UDUth Oncology Costs sharing on Wednesday in Sokoto.

Isa-Obandawaki explained that the initiative was part of the Federal Government efforts to improve access to cancer drugs and improve assistance for patients at convenient rates.

He underlined that the program aimed to reduce the financial burden for families and fill the equity gap in the treatment of cancer.

He expressed optimism on the fact that the initiative would significantly improve economic accessibility and accessibility of cancer assistance for the Nigerians, observing that all registered NHIA members were suitable for benefiting across the country.

A representative of Roche, Mrs. Dara Olateke, said that the initiative was designed to provide high quality services to all Nigerians as part of the formal and informal inscription of the NHIA.

He underlined that the therapies included in the initiative were part of the Roche products range.

Olatoke explained that, based on the costs of costs, Roche would have covered 50 % of the cost of the drug; Nhia would contribute to 30 %, while the patient would be responsible for the remaining 20 %.

He added that Roche’s goal was to make life -saved drugs more accessible and protect patients from financial difficulties that often followed a diagnosis of cancer.

In his observations, the head of the medical director (cmd) of Uduth, Prof. Anas Sabir, described the initiative as a welcome development, recognizing the high cost and complexity of cancer treatment in Nigeria.

Sabir was represented by the president, Medical Advisory Committee (Cmac), Prof. Usman Sani.

He observed that the partnership marked a significant milestone in facing the growing load of cancer in the region.

He assured that the hospital had made adequate agreements for a regular implementation of the program, including an updated data management system to support its success.

Sabir also encouraged Roche to explore further partnerships with other pharmaceutical companies to expand the treatment and drug options.

Dr. Abdulkadir Hassan, responsible for research, of the standard guarantee and quality department, Nia Sokoto, added that the cancer service centers had been expanded from seven to 24 health institutions in all six geopolitical areas of the country.

He said the program also included seminars, seminars and infrastructure updates to support its objectives.

Hassan observed that the individual payment platforms, the supervision mechanisms and administrative processes had been simplified, with financial and bureaucratic obstacles that gave priority to the resolution to ensure the success of the program.

The Nigeria (NAN) news agency reports that the onboarding session included interactive discussions, questions and answers, proposed solutions and challenges relating to the initiative.

(Nan)

Related